Willmore, E. Et Al. 2019. Targeting the MDM2-p53 interaction: evaluation of a novel, potent MDM2-p53 antagonist in patient-derived CLL cells. The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) , (Edinburgh, Saint Helena).

Willmore, E., APTULLAHOĞLU, E., Zhao, Y., Kyle, S., Thomas, H., Ahn, M., ... Fazal, L.(2019). Targeting the MDM2-p53 interaction: evaluation of a novel, potent MDM2-p53 antagonist in patient-derived CLL cells . The International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Edinburgh, Saint Helena

Willmore, Elaine Et Al. "Targeting the MDM2-p53 interaction: evaluation of a novel, potent MDM2-p53 antagonist in patient-derived CLL cells," The International Workshop on Chronic Lymphocytic Leukemia (iwCLL), Edinburgh, Saint Helena, 2019

Willmore, Elaine Et Al. "Targeting the MDM2-p53 interaction: evaluation of a novel, potent MDM2-p53 antagonist in patient-derived CLL cells." The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) , Edinburgh, Saint Helena, 2019

Willmore, E. Et Al. (2019) . "Targeting the MDM2-p53 interaction: evaluation of a novel, potent MDM2-p53 antagonist in patient-derived CLL cells." The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) , Edinburgh, Saint Helena.

@conferencepaper{conferencepaper, author={Elaine Willmore Et Al. }, title={Targeting the MDM2-p53 interaction: evaluation of a novel, potent MDM2-p53 antagonist in patient-derived CLL cells}, congress name={The International Workshop on Chronic Lymphocytic Leukemia (iwCLL)}, city={Edinburgh}, country={Saint Helena}, year={2019}}